Trials / Completed
CompletedNCT03331926
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 199 (actual)
- Sponsor
- Jeppe Lange · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xiapex | Follow-up of effect of treatment |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-05-31
- Completion
- 2019-12-31
- First posted
- 2017-11-06
- Last updated
- 2020-04-22
Source: ClinicalTrials.gov record NCT03331926. Inclusion in this directory is not an endorsement.